Targeting rewired metabolic pathways in pancreatic cancer
Pancreatic cancer cells rewire their metabolism to adapt to their nutritional environment. In this study, we show that targeting a new drug target, PIKfyve, disrupts lipid metabolism and sensitizes pancreatic cancer cells to KRAS-MAPK inhibitors.